This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gutiérrez, O.
Right arrow Articles by Oliver, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gutiérrez, O.
Right arrow Articles by Oliver, A.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, December 2007, p. 4329-4335, Vol. 51, No. 12
0066-4804/07/$08.00+0     doi:10.1128/AAC.00810-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa Isolates from Spanish Hospitals{triangledown}

O. Gutiérrez,1 C. Juan,1 E. Cercenado,2 F. Navarro,3 E. Bouza,2 P. Coll,3 J. L. Pérez,1 and A. Oliver1*

Servicio de Microbiología and Unidad de Investigación, Hospital Son Dureta, Instituto Universitario de Investigación en Ciencias de la Salud (IUNICS), Palma de Mallorca,1 Servicio de Microbiología, Hospital General Universitario Gregorio Marañón, Madrid,2 Servicio de Microbiología, Hospital de la Santa Creu i Sant Pau, and Departament de Genètica i Microbiologia, Universidad Autònoma de Barcelona, Barcelona, Spain3

Received 22 June 2007/ Returned for modification 30 August 2007/ Accepted 3 October 2007

All (236) Pseudomonas aeruginosa isolates resistant to imipenem and/or meropenem collected during a multicenter (127-hospital) study in Spain were analyzed. Carbapenem-resistant isolates were found to be more frequently resistant to all ß-lactams and non-ß-lactam antibiotics than carbapenem-susceptible isolates (P < 0.001), and up to 46% of the carbapenem-resistant isolates met the criteria used to define multidrug resistance (MDR). Pulsed-field gel electrophoresis revealed remarkable clonal diversity (165 different clones were identified), and with few exceptions, the levels of intra- and interhospital dissemination of clones were found to be low. Carbapenem resistance was driven mainly by the mutational inactivation of OprD, accompanied or not by the hyperexpression of AmpC or MexAB-OprM. Class B carbapenemases (metallo-ß-lactamases [MBLs]) were detected in a single isolate, although interestingly, this isolate belonged to one of the few epidemic clones documented. The MBL-encoding gene (blaVIM-2), along with the aminoglycoside resistance determinants, was transferred to strain PAO1 by electroporation, demonstrating its plasmid location. The class 1 integron harboring blaVIM-2 was characterized as well, and two interesting features were revealed: intI1 was found to be disrupted by a 1.1-kb insertion sequence, and a previously undescribed aminoglycoside acetyltransferase-encoding gene [designated aac(6')-32] preceded blaVIM-2. AAC(6')-32 showed 80% identity to AAC(6')-Ib' and the recently described AAC(6')-31, and when aac(6')-32 was cloned into Escherichia coli, it conferred resistance to tobramycin and reduced susceptibility to gentamicin and amikacin. Despite the currently low prevalence of epidemic clones with MDR, active surveillance is needed to detect and prevent the dissemination of these clones, particularly those producing integron- and plasmid-encoded MBLs, given their additional capacity for the intra- and interspecies spread of MDR.

* Corresponding author. Mailing address: Servicio de Microbiología, Hospital Son Dureta, C. Andrea Doria N° 55, 07014 Palma de Mallorca, Spain. Phone and fax: 34 971 175 185. E-mail: aoliver{at}hsd.es

{triangledown} Published ahead of print on 15 October 2007.

Antimicrobial Agents and Chemotherapy, December 2007, p. 4329-4335, Vol. 51, No. 12
0066-4804/07/$08.00+0     doi:10.1128/AAC.00810-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Rodriguez-Martinez, J.-M., Poirel, L., Nordmann, P. (2009). Extended-Spectrum Cephalosporinases in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 53: 1766-1771 [Abstract] [Full Text]  
  • Mulvey, M. R. PhD, Simor, A. E. MD (2009). Antimicrobial resistance in hospitals: How concerned should we be?. CMAJ 180: 408-415 [Full Text]  
  • Jacoby, G. A. (2009). AmpC {beta}-Lactamases. Clin. Microbiol. Rev. 22: 161-182 [Abstract] [Full Text]  
  • Xu, Z., Li, L., Shirtliff, M. E., Alam, M. J., Yamasaki, S., Shi, L. (2009). Occurrence and Characteristics of Class 1 and 2 Integrons in Pseudomonas aeruginosa Isolates from Patients in Southern China. J. Clin. Microbiol. 47: 230-234 [Abstract] [Full Text]  
  • Rossolini, G. M., Luzzaro, F., Migliavacca, R., Mugnaioli, C., Pini, B., De Luca, F., Perilli, M., Pollini, S., Spalla, M., Amicosante, G., Toniolo, A., Pagani, L. (2008). First Countrywide Survey of Acquired Metallo-{beta}-Lactamases in Gram-Negative Pathogens in Italy. Antimicrob. Agents Chemother. 52: 4023-4029 [Abstract] [Full Text]  
  • Juan, C., Beceiro, A., Gutierrez, O., Alberti, S., Garau, M., Perez, J. L., Bou, G., Oliver, A. (2008). Characterization of the New Metallo-{beta}-Lactamase VIM-13 and Its Integron-Borne Gene from a Pseudomonas aeruginosa Clinical Isolate in Spain. Antimicrob. Agents Chemother. 52: 3589-3596 [Abstract] [Full Text]  
  • Kadlec, K., Schwarz, S. (2008). Analysis and distribution of class 1 and class 2 integrons and associated gene cassettes among Escherichia coli isolates from swine, horses, cats and dogs collected in the BfT-GermVet monitoring study. J Antimicrob Chemother 62: 469-473 [Abstract] [Full Text]  
  • Juan, C., Gutierrez, O., Renom, F., Garau, M., Gallegos, C., Alberti, S., Perez, J. L., Oliver, A. (2008). Chronic Respiratory Infections by Mucoid Carbapenemase-Producing Pseudomonas aeruginosa Strains, a New Potential Public Health Problem. Antimicrob. Agents Chemother. 52: 2285-2286 [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»